Patel, N., Lamble, A., Kirsch, I., Shalabi, H., Wang, H., Silbert, S. K., . . . Shah, N. N. CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationPatel, Nisha, et al. CRLF2-rearranged B-cell ALL with Extramedullary Lineage Switch to AML Following CD19-targeted Therapy. BMJ Publishing Group.
MLA (9th ed.) CitationPatel, Nisha, et al. CRLF2-rearranged B-cell ALL with Extramedullary Lineage Switch to AML Following CD19-targeted Therapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.